Kim Dae Hoon, Kim Su Mi, Choi Min Gew, Sohn Tae Sung, Bae Jae Moon, Kim Sung
Department of Surgery, Chungbuk National University Hospital, Cheongju, Korea.
Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
J Gastric Cancer. 2017 Jun;17(2):154-161. doi: 10.5230/jgc.2017.17.e19. Epub 2017 Jun 17.
This study aimed to investigate the correlation between multiple early gastric cancer (MEGC) and multiple primary malignancies during the follow-up of patients with gastrectomy.
The number of primary tumors detected in other organs after gastrectomy for early gastric cancer (EGC) has been increasing because of improved survival and surveillance programs. A total of 3,129 patients underwent radical gastrectomy for treatment of EGC at Samsung Medical Center from January 2000 to December 2005. Of these, 3,057 patients were selected and their medical records were retrospectively analyzed.
Among the 3,057 patients, 148 (4.8%) had MEGC, 84.5% were male, 57.4% were over 60 years old, 42.6% had a macroscopic type EGC IIb main lesion, and 68.9% had well-differentiated tumors with a significantly high incidence of MEGC. There were no differences between patients with solitary early gastric cancer (SEGC) and those with MEGC with regard to overall survival or recurrence-free survival, but MEGC was an independent risk factor for metachronous primary malignancies in other organs (P=0.004, hazard ratio [HR]=2.444).
MEGC is not a risk factor for poor prognosis after curative gastrectomy, but it is a risk factor for metachronous primary malignancies in other organs during postoperative follow-up; therefore, careful surveillance is needed.
本研究旨在调查胃癌切除术后患者随访期间多灶早期胃癌(MEGC)与多原发性恶性肿瘤之间的相关性。
由于生存率提高和监测计划的改进,早期胃癌(EGC)胃切除术后在其他器官中检测到的原发性肿瘤数量一直在增加。2000年1月至2005年12月,共有3129例患者在三星医疗中心接受了根治性胃切除术以治疗EGC。其中,选择了3057例患者,并对他们的病历进行了回顾性分析。
在3057例患者中,148例(4.8%)患有MEGC,84.5%为男性,57.4%年龄超过60岁,42.6%的主要病变为肉眼类型EGC IIb,68.9%的肿瘤分化良好,MEGC发生率显著较高。孤立性早期胃癌(SEGC)患者和MEGC患者在总生存期或无复发生存期方面没有差异,但MEGC是其他器官异时性原发性恶性肿瘤的独立危险因素(P=0.004,风险比[HR]=2.444)。
MEGC不是根治性胃切除术后预后不良的危险因素,但它是术后随访期间其他器官异时性原发性恶性肿瘤的危险因素;因此,需要仔细监测。